Related Experiment Video
Updated: Apr 27, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Live free or die: cell-cell adhesion regulates sensitivity to trail-induced apoptosis
Lisa L Gallegos1, Joan S Brugge1
1Department of Cell Biology, Ludwig Center at Harvard, Boston, MA 02115, USA.
Abstract:
The ability of the death ligand TRAIL to induce tumor cell apoptosis has led to the development of TRAIL-based cancer therapies. Reporting recently in Molecular Cell, Lu et al. (2014) show that the basis for differential TRAIL responses involves clustering of death receptor complexes by E-cadherin and the actin cytoskeleton.
Insights
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cancer therapies are advanced by understanding differential cell responses. E-cadherin and the actin cytoskeleton cluster death receptor complexes, influencing TRAIL
Area of Science:
- Cell biology
- Molecular oncology
- Biochemistry
Background:
- The death ligand TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) can induce apoptosis in tumor cells, making it a target for cancer therapies.
- Differential responses to TRAIL among tumor cells present a challenge for effective therapy development.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying differential TRAIL-induced apoptosis responses in cancer cells.
- To identify key cellular components involved in regulating sensitivity to TRAIL-based cancer therapies.
Main Methods:
- Investigated the role of E-cadherin in TRAIL-mediated apoptosis.
- Analyzed the involvement of the actin cytoskeleton in the formation of death receptor complexes.
- Utilized cell culture models to assess differential TRAIL sensitivity.
Main Results:
- Demonstrated that E-cadherin mediates the clustering of death receptor complexes.
- Showed that the actin cytoskeleton is essential for this clustering process.
- Identified a correlation between the efficiency of death receptor complex clustering and TRAIL sensitivity.
Conclusions:
- E-cadherin and the actin cytoskeleton are critical regulators of TRAIL-induced apoptosis.
- Targeting these components could enhance the efficacy of TRAIL-based cancer therapies.
- Understanding these mechanisms provides insights into differential TRAIL responses in cancer treatment.
More Related Videos
07:40Assay of Adhesion Under Shear Stress for the Study of T Lymphocyte-Adhesion Molecule Interactions
Published on: June 29, 2016
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
The Intrinsic Apoptotic Pathway
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...